# Program in Translational and Experimental Hematology

> **NIH NIH T32** · STANFORD UNIVERSITY · 2021 · $199,232

## Abstract

Benign and malignant blood diseases cause major morbidity and mortality in the US and
are rising in prevalence due to the rapid aging of the American population. Effective
therapies are rare in part because of an insufficient number of physician-scientists and
PhD scientists trained in Hematology research. Our Training Program in Translational
and Experimental Hematology addresses this important problem by supporting the
training of investigators in basic science or translational research in Hematology. We
have designed a Training Program with rigorous research opportunities and close
mentoring by faculty. Our Program provides an outstanding panel of leading experts in
Hematology as Program Faculty to direct fellows in their research endeavors. Physician-
scientists enter the T32 Training Program after clinical training in adult Hematology. PhD
fellows enter the Program directly from the laboratories of Program Faculty through a
competitive process. Physician-scientists interested in translational research and clinical
investigation have the option of pursuing a Master’s Degree in Clinical Epidemiology to
acquire skills in the design of clinical trials. Fellows in the T32 Program receive training
in three broad areas of hematology research: hematopoiesis and stem cell biology;
thrombosis and vascular biology; and immunology and immunotherapy. Research in the
Training Program comprises two years and is enhanced by didactic lectures, outstanding
seminar series and a rich scientific environment. This Training Program in Translational
and Experimental Hematology contributes new biological insights, novel means of
prevention and new therapies for blood disorders through postdoctoral training of fellows
in Hematology research and by preparing future investigators for careers in research in
Hematology.

## Key facts

- **NIH application ID:** 10204084
- **Project number:** 5T32HL120824-08
- **Recipient organization:** STANFORD UNIVERSITY
- **Principal Investigator:** Ravindra Majeti
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $199,232
- **Award type:** 5
- **Project period:** 2014-07-01 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10204084

## Citation

> US National Institutes of Health, RePORTER application 10204084, Program in Translational and Experimental Hematology (5T32HL120824-08). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10204084. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*